SCHEMBL29915535

SCHEMBL29915535

CCOP(=O)(Cc1cc(-c2cccc(CO[Si](C)(C)C(C)(C)C)c2)nn1Cc1ccc(OC)cc1)OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 4/20 0.36
SLC16A3 O15427 2/20 0.35
SLC16A1 P53985 2/20 0.35
MCTS1 Q9ULC4 2/20 0.35
HDAC1 Q13547 2/20 0.35
POLB P06746 1/20 0.34
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
AKR1C3 P42330 3/20 0.34
ASIC1 P78348 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
MET P08581 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20600406 0.90 MAPT (0.40) MAPTSMN1; SMN2SLC16A3SLC16A1MCTS1
SCHEMBL29915357 0.86 SLC16A3 (0.46) SLC16A3SLC16A1MCTS1
SCHEMBL29915423 0.86 MAPT (0.46) MAPTSMN1; SMN2HDAC1POLBMEN1
SCHEMBL29915324 0.84 MAPT (0.43) MAPTSMN1; SMN2HDAC1MEN1HTT
SCHEMBL29915381 0.81 MAPT (0.41) MAPTSMN1; SMN2HDAC1POLBMEN1
SCHEMBL29915468 0.81 PTGDR (0.42) MAPTSMN1; SMN2MEN1HTTKMT2A
SCHEMBL29915488 0.77 MAPT (0.42) MAPTSMN1; SMN2MEN1KMT2ACCNT1
SCHEMBL22613669 0.77 SLC16A3 (0.52) SLC16A3SLC16A1MCTS1
SCHEMBL22613710 0.74 MAPT (0.45) MAPTSMN1; SMN2HDAC1MEN1HTT
SCHEMBL20600063 0.71 MAPT (0.45) MAPTSMN1; SMN2HDAC1MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11440922-B2 Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors Recordati Industria Chimica e Farmacentica S.p.A. (IT) 2022-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11440922-B2 Heterocyclylmethylidene derivatives and their use as modulators of mGluR5 receptors GRM5, GRIK5, GRM2 MAPT 361/4885SMN1; SMN2 2595/4885SLC16A3 1146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.